Financials Oriola Oyj

Equities

OKDBV

FI0009014351

Pharmaceuticals

Real-time Estimate Cboe Europe 10:50:38 2024-04-29 am EDT 5-day change 1st Jan Change
0.983 EUR +2.08% Intraday chart for Oriola Oyj -6.74% -9.65%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 367.1 349.6 362.5 321.2 199.1 180.7 - -
Enterprise Value (EV) 1 486.7 476.6 463.3 297.5 178.5 136 139.9 245.7
P/E ratio 50.6 x 31.7 x 33.4 x -174 x -9.89 x 13.8 x 10.8 x 7.94 x
Yield 4.44% 1.58% 2% 3.45% 6.43% 8.31% 9% 10.4%
Capitalization / Revenue 0.21 x 0.19 x 0.19 x 0.21 x 0.13 x 0.12 x 0.11 x 0.11 x
EV / Revenue 0.28 x 0.26 x 0.25 x 0.2 x 0.12 x 0.09 x 0.09 x 0.15 x
EV / EBITDA 7.4 x 7.61 x 6.51 x 6.48 x 3.43 x 4.04 x 3.79 x 6.19 x
EV / FCF 7.77 x 18.7 x 26.9 x 3.68 x 29.7 x 2.62 x 10.5 x 21.8 x
FCF Yield 12.9% 5.35% 3.71% 27.2% 3.36% 38.2% 9.54% 4.58%
Price to Book 2.33 x 2.02 x 1.67 x 1.4 x 1.16 x 1.09 x 1.05 x 1.02 x
Nbr of stocks (in thousands) 181,401 181,313 181,348 181,377 181,399 181,411 - -
Reference price 2 2.025 1.902 2.005 1.740 1.088 0.9630 0.9630 0.9630
Announcement Date 2/7/20 2/18/21 2/18/22 2/16/23 2/16/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,721 1,801 1,882 1,516 1,494 1,550 1,592 1,675
EBITDA 1 65.8 62.6 71.2 45.9 52.1 33.67 36.88 39.7
EBIT 1 20.5 21 26.3 17.8 16.7 20.57 23.71 26.25
Operating Margin 1.19% 1.17% 1.4% 1.17% 1.12% 1.33% 1.49% 1.57%
Earnings before Tax (EBT) 1 10.1 14.3 14.7 6.9 -17.6 15.18 20.33 26.54
Net income 1 8 11.3 11.3 -2.4 -20.7 11.84 16.23 22.2
Net margin 0.46% 0.63% 0.6% -0.16% -1.39% 0.76% 1.02% 1.33%
EPS 2 0.0400 0.0600 0.0600 -0.0100 -0.1100 0.0700 0.0888 0.1213
Free Cash Flow 1 62.6 25.5 17.2 80.9 6 52 13.35 11.25
FCF margin 3.64% 1.42% 0.91% 5.34% 0.4% 3.36% 0.84% 0.67%
FCF Conversion (EBITDA) 95.14% 40.73% 24.16% 176.25% 11.52% 154.44% 36.2% 28.34%
FCF Conversion (Net income) 782.5% 225.66% 152.21% - - 439.19% 82.24% 50.68%
Dividend per Share 2 0.0900 0.0300 0.0400 0.0600 0.0700 0.0800 0.0867 0.1000
Announcement Date 2/7/20 2/18/21 2/18/22 2/16/23 2/16/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 499 372.7 394.6 480.9 374.2 354.7 383.6 352.6 386.6 375.1 401 371 400
EBITDA 1 23 21.7 10.8 10.5 4.7 7.1 7 8.1 8.4 7 7.9 8.4 9.75
EBIT 1 11.6 15 5.5 6.6 0.9 3.5 3.4 4.4 5.4 4 4.7 5.35 6.85
Operating Margin 2.32% 4.02% 1.39% 1.37% 0.24% 0.99% 0.89% 1.25% 1.4% 1.07% 1.17% 1.44% 1.71%
Earnings before Tax (EBT) 1 6.8 2.7 7.3 6.7 -9.8 1.5 1.5 -19.7 -0.9 -2 -0.5 1.5 3.65
Net income 1 5.3 8.8 12 14.6 -37.9 1.1 1.2 -20.2 -2.8 -2.3 -1 0.8 3
Net margin 1.06% 2.36% 3.04% 3.04% -10.13% 0.31% 0.31% -5.73% -0.72% -0.61% -0.25% 0.22% 0.75%
EPS 2 0.0300 0.0500 0.0700 0.0800 -0.2100 0.0100 0.0100 -0.1100 -0.0200 -0.0100 -0.0100 - 0.0200
Dividend per Share - - - - - - - - - - - - -
Announcement Date 2/18/22 4/28/22 7/22/22 10/27/22 2/16/23 4/27/23 7/21/23 10/31/23 2/16/24 4/25/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 120 127 101 - - - - 65
Net Cash position 1 - - - 23.7 20.6 44.7 40.8 -
Leverage (Debt/EBITDA) 1.818 x 2.029 x 1.416 x - - - - 1.637 x
Free Cash Flow 1 62.6 25.5 17.2 80.9 6 52 13.4 11.3
ROE (net income / shareholders' equity) 7.82% 6.9% 5.9% -1.1% -10.4% 6.93% 9.86% 14.3%
ROA (Net income/ Total Assets) 1.34% 1.08% 1% -0.23% -2.18% 0.28% 1.85% 2.47%
Assets 1 596.9 1,043 1,129 1,027 947.8 4,290 877 897.2
Book Value Per Share 2 0.8700 0.9400 1.200 1.240 0.9400 0.8800 0.9200 0.9500
Cash Flow per Share 2 0.4700 0.3200 0.2200 0.4300 0.0500 0.1600 0.1900 -
Capex 1 21.8 32.8 22.8 8.5 3.6 18.1 21.2 27.3
Capex / Sales 1.27% 1.82% 1.21% 0.56% 0.24% 1.17% 1.33% 1.63%
Announcement Date 2/7/20 2/18/21 2/18/22 2/16/23 2/16/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
0.963 EUR
Average target price
1.125 EUR
Spread / Average Target
+16.82%
Consensus